CN Patent

CN114437079B — 吡咯嘧啶五元氮杂环化合物的晶型

Assigned to Hangzhou Bangshun Pharmaceutical Co Ltd · Expires 2024-11-01 · 2y expired

What this patent protects

本发明公开了一种式(I)所示化合物的游离碱晶型A和磷酸盐晶型B和晶型C，并公开了它们的制备方法和用途。所述游离碱晶型A和磷酸盐晶型B具有很好的稳定性和溶解性，更适合作为制剂原料使用。

USPTO Abstract

本发明公开了一种式(I)所示化合物的游离碱晶型A和磷酸盐晶型B和晶型C，并公开了它们的制备方法和用途。所述游离碱晶型A和磷酸盐晶型B具有很好的稳定性和溶解性，更适合作为制剂原料使用。

Drugs covered by this patent

ruxolitinib-phosphate (RUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: CN114437079B
Jurisdiction: CN
Classification: —
Expires: 2024-11-01
Drug substance claim: No
Drug product claim: No
Assignee: Hangzhou Bangshun Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.